• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿液细胞学诊断进展

Diagnostic Advances in Urine Cytology.

作者信息

Xing Juan, Reynolds Jordan P

机构信息

University of Pittsburgh Medical Center, UPMC Shadyside Hospital, 5150 Centre Avenue, POB2, Suite 201.2, Pittsburgh, PA 15232, USA.

Cleveland Clinic Foundation, Pathology and Laboratory Medicine Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA.

出版信息

Surg Pathol Clin. 2018 Sep;11(3):601-610. doi: 10.1016/j.path.2018.06.001. Epub 2018 Jul 13.

DOI:10.1016/j.path.2018.06.001
PMID:30190143
Abstract

The utility of urine cytology has shifted from the identification of red blood cells, crystals, or parasites to its currently used role of detection of cancer cells exfoliated in urine samples. A variety of ancillary tests have been developed to complement the diagnostic ability of urine cytology. Furthermore, urine testing will continue to evolve as the pathogenesis of genitourinary tract diseases in depth is understood. This article focuses on the diagnostic advances in urine cytology from the cytomorphological perspective, past and current reporting schemes, and the application of ancillary testing in urine samples.

摘要

尿液细胞学的用途已从识别红细胞、晶体或寄生虫转变为目前用于检测尿液样本中脱落癌细胞的作用。已经开发了多种辅助检测方法来补充尿液细胞学的诊断能力。此外,随着对泌尿生殖道疾病发病机制的深入了解,尿液检测将不断发展。本文从细胞形态学角度、过去和当前的报告方案以及辅助检测在尿液样本中的应用等方面,重点介绍尿液细胞学的诊断进展。

相似文献

1
Diagnostic Advances in Urine Cytology.尿液细胞学诊断进展
Surg Pathol Clin. 2018 Sep;11(3):601-610. doi: 10.1016/j.path.2018.06.001. Epub 2018 Jul 13.
2
Reclassification of urinary cytology regarding The Paris System for Reporting Urinary Cytology with cytohistological correlation demonstrates high sensitivity for high-grade urothelial carcinoma.关于《巴黎泌尿系统细胞学报告系统》并结合细胞组织学相关性对泌尿系统细胞学进行重新分类,显示出对高级别尿路上皮癌具有高敏感性。
Diagn Cytopathol. 2020 May;48(5):446-452. doi: 10.1002/dc.24387. Epub 2020 Jan 24.
3
Urinary cytology and the Paris system for reporting urinary cytology: Implications for urological management.尿液细胞学检查及巴黎尿液细胞学报告系统:对泌尿外科管理的影响。
Cytopathology. 2018 Aug;29(4):368-370. doi: 10.1111/cyt.12538. Epub 2018 Mar 25.
4
Evaluation of fluorescence in situ hybridization as an ancillary tool to urine cytology in diagnosing urothelial carcinoma.评估荧光原位杂交作为尿液细胞学辅助工具在诊断尿路上皮癌中的应用。
Diagn Cytopathol. 2003 Jun;28(6):301-7. doi: 10.1002/dc.10291.
5
Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.对膀胱移行细胞癌患者的脱落尿路上皮细胞进行荧光原位杂交。
Urology. 2004 Feb;63(2):398-401. doi: 10.1016/j.urology.2003.08.026.
6
Detection of urinary bladder cancer with flow cytometry and hexaminolevulinate in urine samples.利用流式细胞术和尿样中的六氨基乙酰丙酸检测膀胱癌
Cytopathology. 2007 Apr;18(2):87-95. doi: 10.1111/j.1365-2303.2007.00436.x.
7
Sensitivity and specificity of urine cytology in the screening of transitional cell carcinomas.尿细胞学检查在移行细胞癌筛查中的敏感性和特异性。
Cytopathology. 2002 Dec;13(6):381-2. doi: 10.1046/j.1365-2303.2002.00448_2.x.
8
Utility of the Paris System in Reporting Urine Cytology.巴黎系统在尿液细胞学报告中的应用
Acta Cytol. 2017;61(2):145-152. doi: 10.1159/000464270. Epub 2017 Apr 6.
9
Fluorescence in situ hybridization (FISH) in the diagnosis of bladder and upper tract urothelial carcinoma: the largest single-institution experience to date.荧光原位杂交(FISH)在膀胱和上尿路尿路上皮癌诊断中的应用:迄今为止最大规模的单机构经验。
Can J Urol. 2017 Feb;24(1):8620-8626.
10
Significantly increased accuracy of urothelial carcinoma detection in destained urine slides with combined analysis of standard cytology and CK-20 immunostaing.通过标准细胞学和CK-20免疫染色联合分析,显著提高了脱色尿涂片检测尿路上皮癌的准确性。
Acta Cytol. 2009 May-Jun;53(3):357-60. doi: 10.1159/000325325.

引用本文的文献

1
Unleashing the power of urine‑based biomarkers in diagnosis, prognosis and monitoring of bladder cancer (Review).释放基于尿液的生物标志物在膀胱癌诊断、预后和监测中的力量(综述)。
Int J Oncol. 2025 Mar;66(3). doi: 10.3892/ijo.2025.5724. Epub 2025 Feb 7.
2
S100A8 promotes the proliferation, migration and invasion in bladder cancer cells.S100A8促进膀胱癌细胞的增殖、迁移和侵袭。
J Cancer. 2025 Jan 1;16(4):1066-1077. doi: 10.7150/jca.102201. eCollection 2025.
3
Photodynamic Diagnosis and Therapy in Non-Muscle-Invasive Bladder Cancer.
非肌层浸润性膀胱癌的光动力诊断与治疗
Cancers (Basel). 2024 Jun 22;16(13):2299. doi: 10.3390/cancers16132299.
4
Exosomal DNA: Role in Reflecting Tumor Genetic Heterogeneity, Diagnosis, and Disease Monitoring.外泌体DNA:在反映肿瘤遗传异质性、诊断及疾病监测中的作用
Cancers (Basel). 2023 Dec 21;16(1):57. doi: 10.3390/cancers16010057.
5
Sensitivity of urine cytology in detecting high-grade urothelial carcinoma in patients with neoplastic urinary bladder diverticula: A major cancer center experience.尿细胞学检查在检测伴有肿瘤性膀胱憩室的高级别尿路上皮癌中的敏感性:一家主要癌症中心的经验。
Cancer Cytopathol. 2024 Mar;132(3):144-151. doi: 10.1002/cncy.22782. Epub 2023 Dec 6.
6
Bladder cancer.膀胱癌。
Nat Rev Dis Primers. 2023 Oct 26;9(1):58. doi: 10.1038/s41572-023-00468-9.
7
Urine-Derived Renal Epithelial Cells (URECs) from Transplanted Kidneys as a Promising Immunomodulatory Cell Population.移植肾脏来源的尿路上皮细胞(URECs)作为一种有前途的免疫调节细胞群体。
Cells. 2023 Jun 15;12(12):1630. doi: 10.3390/cells12121630.
8
Bladder cancer biomarkers: Past and future directions.膀胱癌生物标志物:过去与未来的方向
BJUI Compass. 2021 Jan 4;2(1):7-8. doi: 10.1002/bco2.61. eCollection 2021 Jan.
9
The Paris System for Reporting Urinary Cytology: A Meta-Analysis.《巴黎泌尿系统细胞学报告系统:一项荟萃分析》
J Pers Med. 2022 Jan 27;12(2):170. doi: 10.3390/jpm12020170.
10
Toilet-based continuous health monitoring using urine.基于厕所的尿液连续健康监测。
Nat Rev Urol. 2022 Apr;19(4):219-230. doi: 10.1038/s41585-021-00558-x. Epub 2022 Jan 21.